Ezetimibe clearly decreased total cholesterol and LDL levels in the blood of Ldlr−/− mice fed with an ezetimibe-based WD, and also decreased valvular lipid accumulation as well (Fig. 2j, k). This evidence concerns the gene LDLR and Wilson disease.